Keyword: AbbVie

News

Abbott Devices, Generics Struggle

17.04.2013 - Abbott Laboratories on Wednesday reported higher quarterly earnings after splitting off its branded drug business, and the company said demand was strong for its infant formulas...

News

The Future of Pharma

11.04.2013 - The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...

News

Top U.S. Court to Decide on Deals to Delay Cheaper Drugs

23.03.2013 - The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...

News

Amgen Biosimilar Push Takes Aim at Blockbusters

07.02.2013 - Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...

News

AbbVie Forecasts Slower Humira Growth

31.01.2013 - AbbVie, the pharmaceuticals business spun off earlier this month by Abbott Laboratories, forecast 2013 earnings in line with Wall Street forecasts but slowing sales growth for...

News

Abbott Results Bode Well for Spun-off AbbVie

24.01.2013 - AbbVie, the new branded pharmaceuticals company spun off by Abbott Laboratories, is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other products...

News

Drug Industry Bets on New Blockbusters in 2013

16.01.2013 - Drugmakers are betting that a new wave of medicines for cancer, diabetes, heart disease, multiple sclerosis and hepatitis will shape up as tomorrow's blockbusters in the coming 12...

News

Medtech Companies Face Job Cuts

21.12.2012 - The U.S. medical technology industry, once a haven for secure, high-paying jobs, is blaming a new tax meant to help fund the Affordable Care Act for upcoming layoffs. But even if...